
F1000Research, Journal Year: 2024, Volume and Issue: 12, P. 394 - 394
Published: Feb. 5, 2024
Language: Английский
F1000Research, Journal Year: 2024, Volume and Issue: 12, P. 394 - 394
Published: Feb. 5, 2024
Language: Английский
Elsevier eBooks, Journal Year: 2024, Volume and Issue: unknown, P. 485 - 492
Published: Jan. 1, 2024
Language: Английский
Citations
1Journal of International Medical Research, Journal Year: 2024, Volume and Issue: 52(8)
Published: Aug. 1, 2024
Objective We investigated the role of serum 25(OH)D (25-hydroxyvitamin D) in COVID-related health outcomes. Methods conducted a retrospective cross-sectional study using data National Center Disease Control and Public Health, Georgia. extracted patient including length hospital stay, transfer to intensive care unit, requirement for oxygen therapy, treatment with glucocorticoids, symptoms. After obtaining written informed consent, 384 individuals were enrolled. divided participants into three groups according levels: group 1 = <12 ng/mL (n 83), 2 12–20 141), 3 >20 160). Results The odds ratio (OR) hospitalization versus was 8.7 (95% confidence interval [CI] 3.6–21.3) 5.6 CI 2.7–11.9). Regarding OR 28.41 3.7–220.5) 5.2 1.9–14.1). 3.7 1.1–12.5) 8.4 1.8–40.7). Conclusion COVID-19-related morbidity associated decreased levels. Future studies should investigate potential vitamin D sufficiency preventing SARS-CoV-2 infection mortality.
Language: Английский
Citations
1BMC Medical Genomics, Journal Year: 2024, Volume and Issue: 17(1)
Published: Dec. 2, 2024
The vitamin D binding protein (DBP) plays a critical role in both innate and adaptive immune systems, participating several clinical conditions, including coronavirus disease 2019 infection severity, mortality rate. study aimed to investigate the correlation between rs7041 rs4588 polymorphisms DBP gene Coronavirus Disease-2019 (COVID-19) severity mortality, patients of Suez Canal University Hospitals Ismailia, Egypt. A case-control enrolled 220 individuals; 140 COVID-19 80 healthy controls. Serum 25(OH) levels were determined by enzyme-linked immunosorbent assay (ELISA), genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). found that groups had deficiency, which was considerably lower group compared Among patients, there significant difference according indicating can be used as predictors severity. Negative correlations genetic variants CA genotype TT prevalence (p = 0.006 0.009 respectively) proved. No all > 0.05). Positive TG 0.029 0.031 respectively). deficiency increased COVID-19. correlated with mortality.
Language: Английский
Citations
1Cureus, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 20, 2024
Vitamin D deficiency (VDD) is prevalent worldwide and may influence the severity of infectious diseases, including COVID-19. This study aimed to evaluate association between VDD 30-day clinical outcomes in patients with
Language: Английский
Citations
1F1000Research, Journal Year: 2024, Volume and Issue: 12, P. 394 - 394
Published: Feb. 5, 2024
Language: Английский
Citations
0